StoneX Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-218
| Closed | -$229K | – | 907 |
|
|
2024
Q3 | $229K | Buy |
+218
| New | +$229K | 0.1% | 280 |
|
|
2024
Q2 | – | Sell |
-235
| Closed | -$226K | – | 427 |
|
|
2024
Q1 | $226K | Sell |
235
-42
| -15% | -$40.4K | 0.12% | 256 |
|
|
2023
Q4 | $243K | Buy |
277
+27
| +11% | +$23.7K | 0.13% | 238 |
|
|
2023
Q3 | $206K | Buy |
+250
| New | +$206K | 0.11% | 287 |
|
|
2023
Q2 | – | Sell |
-334
| Closed | -$274K | – | 447 |
|
|
2023
Q1 | $274K | Buy |
+334
| New | +$274K | 0.16% | 198 |
|
|
2022
Q2 | – | Sell |
-410
| Closed | -$286K | – | 699 |
|
|
2022
Q1 | $286K | Buy |
410
+33
| +9% | +$23K | 0.03% | 426 |
|
|
2021
Q4 | $238K | Sell |
377
-104
| -22% | -$65.7K | 0.03% | 466 |
|
|
2021
Q3 | $291K | Sell |
481
-6
| -1% | -$3.63K | 0.04% | 368 |
|
|
2021
Q2 | $272K | Buy |
487
+10
| +2% | +$5.59K | 0.04% | 383 |
|
|
2021
Q1 | $226K | Sell |
477
-32
| -6% | -$15.2K | 0.04% | 366 |
|
|
2020
Q4 | $246K | Buy |
509
+5
| +1% | +$2.42K | 0.05% | 307 |
|
|
2020
Q3 | $282K | Buy |
504
+23
| +5% | +$12.9K | 0.09% | 241 |
|
|
2020
Q2 | $300K | Sell |
481
-30
| -6% | -$18.7K | 0.11% | 216 |
|
|
2020
Q1 | $250K | Buy |
+511
| New | +$250K | 0.13% | 200 |
|
|
2018
Q3 | – | Sell |
-674
| Closed | -$233K | – | 244 |
|
|
2018
Q2 | $233K | Buy |
+674
| New | +$233K | 0.2% | 196 |
|
|
2017
Q3 | – | Sell |
-704
| Closed | -$346K | – | 318 |
|
|
2017
Q2 | $346K | Buy |
+704
| New | +$346K | 0.11% | 250 |
|